Opus Genetics (IRD) Other Gross PP&E Adjustments (2011 - 2026)
Opus Genetics (IRD) reported Other Gross PP&E Adjustments of -$1.2 million for Q1 2026, up 69.31% year-over-year from -$737691.2 in Q1 2025, and down 197.38% on a QoQ basis from -$420000.0 in Q4 2025.
Opus Genetics (IRD) has 16 years of Other Gross PP&E Adjustments data on file, last reported at -$1.2 million in Q1 2026.
- Quarterly Other Gross PP&E Adjustments rose 69.31% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.8 million (up 43.08% YoY) and the FY2025 annual result came in at -$420000.0, up 79.36% from the prior year.
- Other Gross PP&E Adjustments slipped to -$1.2 million in Q1 2026 per IRD's latest filing, from -$420000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$79000.0 in Q2 2022 and bottomed at -$4.1 million in Q1 2025.
- The 5-year median for Other Gross PP&E Adjustments is -$948000.0 (2024), against an average of -$1.2 million.
- The widest annual swing landed in 2024, when Other Gross PP&E Adjustments slumped 1108.62%; it then surged 79.36% in 2025.
- Tracing IRD's Other Gross PP&E Adjustments over 5 years: stood at -$1.1 million in 2022, then plunged by 60.6% to -$1.8 million in 2023, then declined by 12.43% to -$2.0 million in 2024, then surged by 79.36% to -$420000.0 in 2025, then plunged by 197.38% to -$1.2 million in 2026.
- Per Business Quant, the three latest IRD Other Gross PP&E Adjustments figures stand at -$1.2 million (Q1 2026), -$420000.0 (Q4 2025), and -$856000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.25 Mn |
| Mar 31, 2026 | -1.25 Mn |
| Dec 31, 2025 | -420,000.00 |
| Dec 31, 2025 | -420,000.00 |
| Sep 30, 2025 | -856,000.00 |
| Sep 30, 2025 | -856,000.00 |
| Jun 30, 2025 | -3.23 Mn |
| Jun 30, 2025 | -3.23 Mn |
| Mar 31, 2025 | -4.07 Mn |
| Mar 31, 2025 | -4.07 Mn |
| Dec 31, 2024 | -2.04 Mn |
| Dec 31, 2024 | -2.04 Mn |
| Sep 30, 2024 | -948,000.00 |
| Sep 30, 2024 | -948,000.00 |
| Jun 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -1.61 Mn |
| Mar 31, 2024 | -1.61 Mn |
| Dec 31, 2023 | -1.81 Mn |
| Dec 31, 2023 | -1.81 Mn |
| Sep 30, 2023 | -237,000.00 |
| Sep 30, 2023 | -237,000.00 |
| Jun 30, 2023 | -116,000.00 |
| Jun 30, 2023 | -116,000.00 |
| Mar 31, 2023 | -197,000.00 |
| Mar 31, 2023 | -197,000.00 |
| Dec 31, 2022 | -1.13 Mn |
| Dec 31, 2022 | -1.13 Mn |
| Sep 30, 2022 | -161,000.00 |
| Sep 30, 2022 | -161,000.00 |
| Jun 30, 2022 | -79,000.00 |
| Jun 30, 2022 | -79,000.00 |
| Mar 31, 2022 | -164,000.00 |
| Mar 31, 2022 | -164,000.00 |
| Dec 31, 2021 | -786,000.00 |
| Dec 31, 2021 | -786,000.00 |
| Sep 30, 2021 | -242,000.00 |
| Sep 30, 2021 | -242,000.00 |
| Jun 30, 2021 | -147,000.00 |
| Jun 30, 2021 | -147,000.00 |
| Mar 31, 2021 | -137,000.00 |
| Mar 31, 2021 | -137,000.00 |
| Dec 31, 2020 | -441,000.00 |
| Dec 31, 2020 | -441,000.00 |
| Sep 30, 2020 | -314,633.00 |
| Sep 30, 2020 | -314,633.00 |
| Jun 30, 2020 | -331,984.00 |
| Jun 30, 2020 | -331,984.00 |
| Mar 31, 2020 | -375,377.00 |
| Mar 31, 2020 | -375,377.00 |
| Dec 31, 2019 | -440,348.00 |
| Dec 31, 2019 | -440,348.00 |
| Sep 30, 2019 | -1.16 Mn |
| Sep 30, 2019 | -1.16 Mn |
| Jun 30, 2019 | -1.17 Mn |
| Jun 30, 2019 | -1.17 Mn |
| Mar 31, 2019 | -1.54 Mn |
| Mar 31, 2019 | -1.54 Mn |
| Dec 31, 2018 | -786,410.00 |
| Dec 31, 2018 | -786,410.00 |
| Sep 30, 2018 | -736,410.00 |
| Sep 30, 2018 | -736,410.00 |
| Jun 30, 2018 | -759,142.00 |
| Jun 30, 2018 | -759,142.00 |
| Mar 31, 2018 | -756,115.00 |
| Mar 31, 2018 | -756,115.00 |
| Dec 31, 2017 | -624,694.00 |
| Dec 31, 2017 | -624,694.00 |
| Sep 30, 2017 | -1.17 Mn |
| Sep 30, 2017 | -1.17 Mn |
| Jun 30, 2017 | -1.33 Mn |
| Jun 30, 2017 | -1.33 Mn |
| Mar 31, 2017 | -1.29 Mn |
| Mar 31, 2017 | -1.29 Mn |
| Dec 31, 2016 | -1.21 Mn |
| Dec 31, 2016 | -1.21 Mn |
| Sep 30, 2016 | -1.29 Mn |
| Sep 30, 2016 | -1.29 Mn |
| Jun 30, 2016 | -1.15 Mn |
| Jun 30, 2016 | -1.15 Mn |
| Mar 31, 2016 | -1.27 Mn |
| Mar 31, 2016 | -1.27 Mn |
| Dec 31, 2015 | -1.14 Mn |
| Dec 31, 2015 | -1.14 Mn |
| Sep 30, 2015 | -1.74 Mn |
| Sep 30, 2015 | -1.74 Mn |
| Jun 30, 2015 | -1.69 Mn |
| Jun 30, 2015 | -1.69 Mn |
| Mar 31, 2015 | -1.59 Mn |
| Mar 31, 2015 | -1.59 Mn |
| Dec 31, 2014 | -1.53 Mn |
| Dec 31, 2014 | -1.53 Mn |
| Sep 30, 2014 | -1.47 Mn |
| Sep 30, 2014 | -1.47 Mn |
| Jun 30, 2014 | -1.42 Mn |
| Jun 30, 2014 | -1.42 Mn |
| Mar 31, 2014 | -1.41 Mn |
| Mar 31, 2014 | -1.41 Mn |
| Dec 31, 2013 | -1.38 Mn |
| Dec 31, 2013 | -1.38 Mn |
| Sep 30, 2013 | -2.00 Mn |
| Sep 30, 2013 | -2.00 Mn |
| Jun 30, 2013 | -2.01 Mn |
| Jun 30, 2013 | -2.01 Mn |
| Mar 31, 2013 | -1.99 Mn |
| Mar 31, 2013 | -1.99 Mn |
| Dec 31, 2012 | -1.84 Mn |
| Dec 31, 2012 | -1.84 Mn |
| Sep 30, 2012 | -1.83 Mn |
| Sep 30, 2012 | -1.83 Mn |
| Jun 30, 2012 | -1.81 Mn |
| Jun 30, 2012 | -1.81 Mn |
| Dec 31, 2011 | -1.75 Mn |
| Dec 31, 2011 | -1.75 Mn |